Pharmacogenetics of addiction therapy.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Methods in molecular biology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/978-1-4939-0956-8_15PMID 25150877
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association of GATA4 sequence variation with alcohol dependence

  2014cited by this paper
• DBH gene as predictor of response in a cocaine vaccine clinical trial.

  2013cited by this paper
• Positive association between--1021TT genotype of dopamine beta hydroxylase gene and progressive behavior of injection heroin users.

  2013cited by this paper
• µ-Opioid Receptor Gene (OPRM1) Polymorphism A118G: Lack of Association in Finnish Populations with Alcohol Dependence or Alcohol Consumption

  2013cited by this paper
• Association of functional DBH genetic variants with alcohol dependence risk and related depression and suicide attempt phenotypes: results from a large multicenter association study.

  2013cited by this paper
• BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases

  2013cited by this paper
• Contribution of CYP2B6 alleles in explaining extreme (S)-methadone plasma levels: a CYP2B6 gene resequencing study

  2013cited by this paper
• An Intronic Variant in OPRD1 Predicts Treatment Outcome for Opioid Dependence in African-Americans

  2013cited by this paper
• Pharmacogenetic randomized trial for cocaine abuse: disulfiram and α1A-adrenoceptor gene variation.

  2013cited by this paper
• Opioid system genes in alcoholism: a case-control study in Croatian population.

  2013cited by this paper
• Serotonin transporter genotype and mild traumatic brain injury independently influence resilience and perception of limitations in veterans.

  2013cited by this paper
• The association between DRD2/ANKK1 and genetically informed measures of alcohol use and problems

  2013cited by this paper
• The &kgr;-opioid receptor gene as a predictor of response in a cocaine vaccine clinical trial

  2013cited by this paper
• The MTHFR C677T Variant is Associated with Responsiveness to Disulfiram Treatment for Cocaine Dependency

  2013cited by this paper
• Association of BDNF gene polymorphisms with schizophrenia and clinical symptoms in a Chinese population

  2013cited by this paper
• The μ-opioid receptor and treatment response to naltrexone.

  2013cited by this paper
• Pharmacogenetic randomized trial for cocaine abuse: disulfiram and dopamine β-hydroxylase.

  2013cited by this paper
• ANKK1 and DRD2 pharmacogenetics of disulfiram treatment for cocaine abuse

  2013cited by this paper
• CYP2B6 SNPs are associated with methadone dose required for effective treatment of opioid addiction

  2013cited by this paper
• An Integrated Encyclopedia of DNA Elements in the Human Genome

  2012cited by this paper
• ABCB1 haplotype and OPRM1 118A > G genotype interaction in methadone maintenance treatment pharmacogenetics

  2012cited by this paper
• Pharmacogenetics of Naltrexone in Asian Americans: A Randomized Placebo-Controlled Laboratory Study

  2012cited by this paper
• A new control center for dopaminergic systems: pulling the VTA by the tail.

  2012cited by this paper
• GIRK2 expression in dopamine neurons of the substantia nigra and ventral tegmental area

  2012cited by this paper
• An integrated map of genetic variation from 1,092 human genomes

  2012cited by this paper
• Maintenance Medication for Opiate Addiction: The Foundation of Recovery

  2012cited by this paper
• Personalized Treatment of Alcohol Dependence

  2012cited by this paper
• Modifying the role of serotonergic 5‐HTTLPR and TPH2 variants on disulfiram treatment of cocaine addiction: a preliminary study

  2012cited by this paper
• OPRM1 A118G genotype fails to predict the effectiveness of naltrexone treatment for alcohol dependence

  2011cited by this paper
• BDNF Polymorphism Predicts General Intelligence after Penetrating Traumatic Brain Injury

  2011cited by this paper
• The ANKK1 Protein Associated with Addictions has Nuclear and Cytoplasmic Localization and Shows a Differential Response of Ala239Thr to Apomorphine

  2011cited by this paper
• Intronic Polymorphisms Affecting Alternative Splicing of Human Dopamine D2 Receptor Are Associated with Cocaine Abuse

  2011cited by this paper
• Impact of genetic polymorphisms in ABCB1, CYP2B6, OPRM1, ANKK1 and DRD2 genes on methadone therapy in Han Chinese patients.

  2011cited by this paper
• The dynorphin/κ-opioid receptor system and its role in psychiatric disorders

  2011cited by this paper
• The Serotonin Transporter Gene Alters Sensitivity to Attention Bias Modification: Evidence for a Plasticity Gene

  2011cited by this paper
• β-Arrestin2 influences the response to methadone in opioid-dependent patients

  2011cited by this paper
• A Double-Blind, Randomized Trial of Sertraline for Alcohol Dependence: Moderation by Age of Onset and 5-Hydroxytryptamine Transporter-Linked Promoter Region Genotype

  2011cited by this paper
• Tryptophan hydroxylase-2 (TPH2) in disorders of cognitive control and emotion regulation: a perspective.

  2011cited by this paper
• Pharmacogenetic approach at the serotonin transporter gene as a method of reducing the severity of alcohol drinking.

  2011cited by this paper
• The effect of naltrexone on alcohol's stimulant properties and self-administration behavior in social drinkers: influence of gender and genotype.

  2011cited by this paper
• Nerve growth factor beta polypeptide (NGFB) genetic variability: association with the methadone dose required for effective maintenance treatment

  2011cited by this paper
• KCNJ6 is Associated with Adult Alcohol Dependence and Involved in Gene × Early Life Stress Interactions in Adolescent Alcohol Drinking

  2011cited by this paper
• Pharmacogenetic approaches to the treatment of alcohol addiction

  2011cited by this paper
• Novel pharmacotherapeutic treatments for cocaine addiction

  2011cited by this paper
• Disulfiram is a DNA demethylating agent and inhibits prostate cancer cell growth

  2011cited by this paper
• Involvement of the atrial natriuretic peptide transcription factor GATA4 in alcohol dependence, relapse risk and treatment response to acamprosate

  2011cited by this paper
• A KCNJ6 (Kir3.2, GIRK2) gene polymorphism modulates opioid effects on analgesia and addiction but not on pupil size

  2010cited by this paper
• DNA Methylation Regulates Cocaine-Induced Behavioral Sensitization in Mice

  2010cited by this paper
• Increased Abundance of Opioid Receptor Heteromers After Chronic Morphine Administration

  2010cited by this paper
• Disulfiram: an old therapeutic with new applications.

  2010cited by this paper
• A map of human genome variation from population-scale sequencing

  2010cited by this paper
• A genetic determinant of the striatal dopamine response to alcohol in men

  2010cited by this paper
• Impact of 5,10-methylenetetrahydrofolate reductase gene polymorphism on neural tube defects.

  2010cited by this paper
• Single‐nucleotide polymorphism (A118G) in exon 1 of OPRM1 gene causes alteration in downstream signaling by mu‐opioid receptor and may contribute to the genetic risk for addiction

  2010cited by this paper
• Dopamine-β-hydroxylase

  2010cited by this paper
• Acamprosate: a prototypic neuromodulator in the treatment of alcohol dependence.

  2010cited by this paper
• Response to Methadone Maintenance Treatment is Associated with the MYOCD and GRM6 Genes

  2010cited by this paper
• Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution

  2009cited by this paper
• C957T polymorphism of the human dopamine D2 receptor gene predicts extrastriatal dopamine receptor availability in vivo.

  2009cited by this paper
• Genome-wide association study of alcohol dependence.

  2009cited by this paper
• CLINICAL STUDY: Predicting the effect of naltrexone and acamprosate in alcohol‐dependent patients using genetic indicators

  2009cited by this paper
• Pharmacogenetic Treatments for Drug Addiction: Cocaine, Amphetamine and Methamphetamine

  2009cited by this paper
• The neurobiology of individual differences in complex behavioral traits.

  2009cited by this paper
• OPRM1 Asn40Asp predicts response to naltrexone treatment: a haplotype-based approach.

  2009cited by this paper
• Association between KCNJ6 (GIRK2) Gene Polymorphisms and Postoperative Analgesic Requirements after Major Abdominal Surgery

  2009cited by this paper
• A within-group design of nontreatment seeking 5-HTTLPR genotyped alcohol-dependent subjects receiving ondansetron and sertraline.

  2009cited by this paper
• Genetic susceptibility to schizophrenia: role of dopaminergic pathway gene polymorphisms.

  2009cited by this paper
• The role of genetic variation in the causation of mental illness: an evolution-informed framework

  2009cited by this paper
• Pharmacogenetic Treatments for Drug Addiction: Alcohol and Opiates

  2008cited by this paper
• An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study.

  2008cited by this paper
• Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment.

  2008cited by this paper
• Behavioral and Brain Functions

  2008cited by this paper
• Correlation of Plasma Dopamine β-hydroxylase Activity with Polymorphisms in DBH Gene: A Study on Eastern Indian Population

  2008cited by this paper
• The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk

  2008cited by this paper
• Exposure to the Taste of Alcohol Elicits Activation of the Mesocorticolimbic Neurocircuitry

  2008cited by this paper
• A mu opioid receptor gene polymorphism (A118G) and naltrexone treatment response in adherent Korean alcohol-dependent patients

  2008cited by this paper
• Genotype patterns that contribute to increased risk for or protection from developing heroin addiction

  2008cited by this paper
• ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence.

  2008cited by this paper
• Genetic susceptibility to heroin addiction: a candidate gene association study

  2008cited by this paper
• What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review.

  2008cited by this paper
• The value of CYP2D6 and OPRM1 pharmacogenetic testing for opioid therapy.

  2008cited by this paper
• TPH2 and TPH1: Association of Variants and Interactions with Heroin Addiction

  2008cited by this paper
• BDNF variability in opioid addicts and response to methadone treatment: preliminary findings

  2008cited by this paper
• Imaging the Addicted Human Brain

  2007cited by this paper
• Novel 5-HTTLPR allele associates with higher serotonin transporter binding in putamen: a [(11)C] DASB positron emission tomography study.

  2007cited by this paper
• The single nucleotide polymorphism A118G alters functional properties of the human mu opioid receptor

  2007cited by this paper
• Association of CYP2D6 ultrarapid metabolizer genotype with deficient patient satisfaction regarding methadone maintenance treatment.

  2007cited by this paper
• Analysis of tryptophan hydroxylase I and II mRNA expression in the human brain: a post-mortem study.

  2007cited by this paper
• Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory

  2007cited by this paper
• Tryptophan hydroxylase 2 (TPH2) haplotypes predict levels of TPH2 mRNA expression in human pons

  2007cited by this paper
• Genes associated with addiction

  2007cited by this paper
• Disulfiram effects on responses to intravenous cocaine administration.

  2007cited by this paper
• Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study.

  2007cited by this paper
• In vitro P-Glycoprotein-Mediated Transport of (R)-, (S)-, (R,S)-Methadone, LAAM and Their Main Metabolites

  2007cited by this paper
• Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs

  2006cited by this paper
• Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder.

  2006cited by this paper
• Neurotrophins: mediators and modulators of pain.

  2006cited by this paper
• Pharmacogenomics: a path to predictive medicine for schizophrenia.

  2006cited by this paper
• ABCB1 genetic variability and methadone dosage requirements in opioid‐dependent individuals

  2006cited by this paper
• Dopamine β-Hydroxylase Knockout Mice have Alterations in Dopamine Signaling and are Hypersensitive to Cocaine

  2006cited by this paper

• Precision Medicine in Substance Use Disorders: Integrating Behavioral, Environmental, and Biological Insights.

  2025influential citation
• Pharmacogenomic and Pharmacomicrobiomic Aspects of Drugs of Abuse

  2025cites this paper
• SNP-based and haplotype-based genome-wide association on drug dependence in Han Chinese

  2024cites this paper
• Drug addiction: from bench to bedside

  2021cites this paper
• Molecular genetics of cocaine use disorders in humans

  2021cites this paper
• The Relationship between Different Amounts of Physical Exercise, Internal Inhibition, and Drug Craving in Individuals with Substance-Use Disorders

  2021cites this paper
• References

  2020cites this paper
• Psychopharmacology

  2020cites this paper
• Substance Use Disorders

  2020cites this paper
• Psychiatric Disorders, Personality, and Developmental Factors

  2020cites this paper
• Cannabis Use Disorders

  2020cites this paper
• The Biopsychosocial Perspective and Research Methods for Investigation of Substance Use Disorders

  2020cites this paper
• Use Disorders of Cocaine and Methamphetamine

  2020cites this paper
• Opioid Use Disorders

  2020cites this paper
• Tranquilizers and Sedative Use Disorders

  2020cites this paper
• Alcohol Use Disorders

  2020cites this paper
• Treatment of Substance Use Disorders

  2020cites this paper
• Tobacco Use and Nicotine Addiction

  2020cites this paper
• Behavioral, Cognitive, and Social Factors Promoting SUD

  2020cites this paper
• Genetic Influence on Substance Use Disorders

  2020cites this paper
• Preface

  2020cites this paper
• Diagnosis of Substance Use Disorders

  2020cites this paper
• Brain Function and Substance Use Disorders

  2020cites this paper
• Alcohol

  2019cites this paper
• Genetic association of human Corticotropin-Releasing Hormone Receptor 1 (CRHR1) with Internet gaming addiction in Korean male adolescents

  2018cites this paper
• Genetic moderation of cocaine subjective effects by variation in the TPH1, TPH2, and SLC6A4 serotonin genes

  2017cites this paper
• Boosting of Thalamic D2 Dopaminergic Transmission: A Potential Strategy for Drug-Seeking Attenuation

  2017cites this paper
• Integrative Bayesian analysis of neuroimaging-genetic data with application to cocaine dependence

  2016cites this paper
• Opioid Use Disorders.

  2016cites this paper
• Addiction pharmacogenetics: a systematic review of the genetic variation of the dopaminergic system

  2015cites this paper
• The Disease Concept

  1967cites this paper